What Blood Work Can and Cannot Tell You About Your Health and Disease Risk

Blood tests feel reassuring because they produce objective numbers and reference ranges. Many health-conscious people and clinicians lean on them to answer a basic question: am I healthy? This episode of The Peter Attia Drive argues that the answer is far more nuanced, and that misreading labs can create false comfort or needless anxiety.

Peter Attia frames health through lifespan, healthspan and the function of fundamental organ systems. He explains that labs are most useful when tracked longitudinally, since the direction and rate of change in a marker often matter more than any one value. He then reviews the strengths and blind spots of blood work for the major chronic diseases: cardiovascular disease, metabolic dysfunction, cancer and neurodegenerative disease. For metabolic health, he notes that body composition, behavior and functional testing add information labs cannot. For cancer and dementia, he discusses the roles of genetics, cardiometabolic markers and emerging blood-based biomarkers.

A central theme is that more testing does not necessarily produce better decisions. He discusses how to evaluate large direct-to-consumer panels and why sophisticated measures such as lipid subfractionation, biological-age scores and sleep scores often lack clear clinical actionability. He also emphasizes that physical function, cognitive performance and emotional health, all critical to healthspan, cannot be adequately assessed through blood draws.

The practical implication is a framework for evaluating any lab test: understand what it measures, recognize its limitations, and ask whether the result would meaningfully change a decision. Labs should be placed in context alongside imaging, body composition and performance testing.

A caveat is that this summary is based only on the episode description and chapter list. The full discussion is available to subscribers, so specific thresholds, data and recommendations are not covered here.